{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:48:48Z","timestamp":1782730128506,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12325-016-0373-y","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T13:24:11Z","timestamp":1467811451000},"page":"1452-1459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells"],"prefix":"10.1007","volume":"33","author":[{"given":"Tadashi","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tairo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Suzumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomihiko","family":"Tanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tatemichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,6]]},"reference":[{"key":"373_CR1","first-page":"297","volume":"16","author":"DR Anderson","year":"2003","unstructured":"Anderson DR. Collaborative normal tension glaucoma study. Curr Opin Oppthalmol. 2003;16:297\u2013303.","journal-title":"Curr Opin Oppthalmol"},{"key":"373_CR2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","volume":"112","author":"R Valk Van der","year":"2005","unstructured":"Van der Valk R, Webers CA, Schouten JS, et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology. 2005;112:1177\u201385.","journal-title":"Ophthalmology"},{"key":"373_CR3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","volume":"385","author":"DF Garway-Heath","year":"2015","unstructured":"Garway-Heath DF, Crabb DP, Bunce C. Latanoprost for open-angle glaucoma (UKGTS): a randomized, multicenter, placebo-controlled trial. Lancet. 2015;385:1295\u2013304.","journal-title":"Lancet"},{"key":"373_CR4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2147\/OPTH.S63760","volume":"8","author":"JK Schmier","year":"2014","unstructured":"Schmier JK, Hulme-Lowe CK, Covert DW. Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs. Clin Ophthalmol. 2014;8:1097\u2013104.","journal-title":"Clin Ophthalmol"},{"key":"373_CR5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/archophthalmol.2010.131","volume":"128","author":"AP Tanna","year":"2010","unstructured":"Tanna AP, Rademaker AW, Stewart WC, Feldman RM. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs. Arch Ophthalmol. 2010;128:825\u201333.","journal-title":"Arch Ophthalmol"},{"key":"373_CR6","first-page":"539","volume-title":"Glaucoma volume 1: medical diagnosis and therapy","author":"G Holl\u00f3","year":"2009","unstructured":"Holl\u00f3 G. Carbonic anhydrase inhibitors. In: Shaarawy T, Sherwood M, Hitchings R, Crowston J, editors. Glaucoma volume 1: medical diagnosis and therapy. Philadelphia: Elsevier & Saunders; 2009. p. 539\u201346."},{"key":"373_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9394(98)00438-3","volume":"127","author":"A Konowal","year":"1999","unstructured":"Konowal A, Morrison JC, Brown SV, Cooke DL, Maguire LJ, Verdier DV, et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol. 1999;127:403\u20136.","journal-title":"Am J Ophthalmol"},{"key":"373_CR8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1034\/j.1600-0420.1998.760114.x","volume":"76","author":"S Kaminski","year":"1998","unstructured":"Kaminski S, Hommer A, Koyuncu D, Biowski R, Barisani T, Baumgartner I. Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. Acta Ophthalmol Scand. 1998;76:78\u20139.","journal-title":"Acta Ophthalmol Scand"},{"key":"373_CR9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archopht.116.8.1003","volume":"116","author":"JH Lass","year":"1998","unstructured":"Lass JH, Khosrof SA, Laurence JK, Horwitz B, Ghosh K, Adamsons I, the Dorzolamide Corneal Effects Study Group. A double-masked, randomized 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Arch Ophthalmol. 1998;116:1003\u201310.","journal-title":"Arch Ophthalmol"},{"key":"373_CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/IJG.0b013e31815072fe","volume":"17","author":"K Miura","year":"2008","unstructured":"Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. J Glaucoma. 2008;17:233\u20137.","journal-title":"J Glaucoma"},{"key":"373_CR11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/IJG.0b013e318033b491","volume":"16","author":"K Nakamoto","year":"2007","unstructured":"Nakamoto K, Yasuda N. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma. J Glaucoma. 2007;16:352\u20137.","journal-title":"J Glaucoma"},{"key":"373_CR12","first-page":"41","volume":"123","author":"BE Prum Jr","year":"2016","unstructured":"Prum BE Jr, Rosenberg LF, Gedde SJ, Mansberger SL, Stein JD, Moroi SE, Herndon LW Jr, Lim MC, Williams RD. Primary Open-Angle Glaucoma Preferred Practice Pattern\u00ae Guidelines. Ophthalmology. 2016;123:41\u2013111.","journal-title":"Ophthalmology"},{"key":"373_CR13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1442-9071.2004.00908.x","volume":"32","author":"MJ Walland","year":"2004","unstructured":"Walland MJ. Glaucoma treatment in Australia: changing patterns of therapy 1994\u20132003. Clin Exp Ophthalmol. 2004;32:590\u20136.","journal-title":"Clin Exp Ophthalmol"},{"key":"373_CR14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/IJG.0b013e31829ea2e6","volume":"24","author":"JC Lin","year":"2015","unstructured":"Lin JC. The use of ocular hypotensive drugs for glaucoma treatment: changing trend in Taiwan from 1997 to 2007. J Glaucoma. 2015;24:364\u201371.","journal-title":"J Glaucoma"},{"key":"373_CR15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ophtha.2009.01.036","volume":"116","author":"JW Cheng","year":"2009","unstructured":"Cheng JW, Cai JP, Wei RL. Meta-analysis of medical intervention for normal tension glaucoma. Ophthalmology. 2009;116:1243\u20139.","journal-title":"Ophthalmology"},{"key":"373_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1607-551X(09)70384-5","volume":"23","author":"KY Wu","year":"2007","unstructured":"Wu KY, Wang HZ, Hong SJ. Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells. Kaohsiung J Med Sci. 2007;23:105\u201311.","journal-title":"Kaohsiung J Med Sci"},{"key":"373_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1607-551X(09)70222-0","volume":"22","author":"KY Wu","year":"2006","unstructured":"Wu KY, Hong SJ, Wang HZ. Effects of antiglaucoma drugs on calcium mobility in cultured corneal endothelial cells. Kaohsiung J Med Sci. 2006;22:60\u20137.","journal-title":"Kaohsiung J Med Sci"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-016-0373-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0373-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:55:28Z","timestamp":1498326928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0373-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,6]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["373"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0373-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,6]]}}}